Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce
| Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices : report to the Committee on Energy and Commerce |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2016 |
| Descrizione fisica | 1 online resource (iii, 57 pages) : color illustrations, color map |
| Soggetto topico |
Drugs - Safety measures - Evaluation
Pharmaceutical industry - Quality control - Evaluation Drugs - Safety regulations - Evaluation Imports - Safety measures - Evaluation |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety, FDA has improved its foreign drug inspection program, but needs to assess the effectiveness and staffing of its foreign offices |
| Record Nr. | UNINA-9910707980503321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley
| Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2020 |
| Descrizione fisica | 1 online resource (26 pages) : color illustrations, color maps |
| Collana | Testimony |
| Soggetto topico |
COVID-19 (Disease) - Treatment - United States
Drugs - Inspection - United States Drugs - United States - Safety measures - Evaluation Pharmaceutical industry - Quality control - Evaluation Drugs - Safety regulations - United States - Evaluation Drug reimportation - United States - Evaluation Imports - United States - Safety measures - Evaluation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910713508703321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
